Beyaz is Bayer’s attempt to capitalize on the unprecedented level of direct-to-consumer advertising it did with Yaz. Yaz has been on its way out following extensive reports of medical complications, including deep vein thrombosis (blood clots), pulmonary embolism (PE), strokes, heart attacks and gallbladder problems, among others. Bayer has been punished by the FDA for over-the-top Yaz advertising, and it is being punished in the courts by women who have taken the drug and suffered devastating medical consequences. Bayer has already reached a settlement in approximately 70 Yaz lawsuits with many more expected settlements coming down the pike.
So, Bayer updates Yaz with a drug that is “Beyond Yaz.” The advertising is the same—you’ve never seen happier women in your life. Beyaz, unfortunately, is also the same. It has the same ingredients as Yaz—estrogen and the dangerous “fourth generation” hormone drospirenone. The change is an added ingredient—folate—which is historically used to prevent birth defects.
Of course, the point of a birth control pill is to avoid pregnancy but certainly this is a good idea. But the risks of Yaz are still alive with Beyaz. What we have is the same old pill with an updated name (and, of course, Bayer's marketing machine behind Beyaz).The Dangers of Beyaz
On September 26, 2011, the FDA told us that birth control medications that contain drospirenone could potentially cause blood clots. Why? The data the FDA looked at found that drospirenone increases the the risk of blood clots 1.5 times the risk of in other birth control drugs. So now we go "Beyond Yaz" to Beyaz but we still have drospirenone. Keep in mind, this is a Bayer thing, drospirenone was not used in birth control pills before Yaz and Yasmin came into the market. The hormone does not have the same track record for safety as other progestins. So women who take Beyaz may be at a higher risk for:
- Deep Vein Thrombosis (DVT—blood clots)
- Pulmonary Embolism (PE)
- Heart Attack
- Kidney Failure
Obviously, Beyaz-manufacturer Bayer is working on phasing out Yaz and Yasmin (with their decreasing market share), and replacing them with Beyaz, which was approved by the FDA in September 2010. Importantly, that approval was piggybacked on the Yaz approval, further evidence of how similar the drugs are. Regardless, the medical literature is now catching up with regard to Beyaz injuries.
Our lawyers are investigating Beyaz lawsuits. When these cases are filed, they will likely be grouped together in a class-action like MDL, just like the Yaz and Yasmin cases. In an MDL or “mass tort” setting, cases are filed individually, and then grouped together for the purpose of common discovery and possible settlement.Do I Have a Beyaz Claim?
If you or a loved one has used Beyaz and suffered from blood clots, stroke, deep vein thrombosis, heart attack, please call one of our Beyaz attorneys at 800-553-8082 or click here for a free no obligation consultation on your potential Beyaz lawsuit.For More Information